Rare diseases
Investigational molecules
Locations
Sydmarken 11, 2860 Soeborg, Denmark
Clinical research in short bowel syndrome focuses on patients with intestinal failure, including studies assessing long-term treatment use, efficacy, and safety in this gastrointestinal disorder. The portfolio also includes work in SBS-IF populations.
Research activity in this area centers on therapies aimed at improving intestinal function and supporting chronic management of malabsorption-related disease.
Zealand Pharma A/S runs clinical trials in conditions such as Short-bowel syndrome, Weight control, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure
AustriaStudy on Petrelintide for Weight Loss in Overweight or Obese Patients with Related Health Issues
PolandA Study to Evaluate the Long-Term Safety of Glepaglutide in Adult Patients with Short Bowel Syndrome Who Participated in Previous Studies
Belgium
GermanyStudy on the Long-Term Safety of Glepaglutide for Adults with Short Bowel Syndrome
BelgiumStudy on the Long-Term Safety and Effectiveness of Glepaglutide for Patients with Short Bowel Syndrome
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
